Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration

@article{Matri2010IntravitrealIO,
  title={Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration},
  author={Leila el Matri and Ahmed Chebil and Fadra Kort and Rym Bouraoui and Karim Baklouti and Fatma Mghaieth},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={2010},
  volume={248},
  pages={779-784}
}
To discuss the effect and outcome of a combined intravitreal triamcinolone acetonide (IVTA) injection with intravitreal bevacizumab (IVB) in treating choroidal neovascularization (CNV) associated with large retinal pigment epithelial detachment (PED) in age-related macular degeneration (AMD). Prospective, consecutive, observational case series. Seven eyes (five patients) with CNV associated with large PED in AMD were treated by IVTA (4 mg/ 0.1 ml), followed by a IVB (1.25 mg/0.05 ml) 1 week… CONTINUE READING